In this video, Drs Nicolas Van Mieghem, Christopher Meduri, and Azeem Latib discuss the biomimetic design of the DurAVR® transcatheter heart valve (THV) and its impact on hemodynamics and blood flow dynamics. Learn about:

• The history of Anteris Technologies, which started as a company developing and commercializing anti-calcification tissue.
• The single-piece, native-shaped biomimetic design of the DurAVR® THV, a new class of TAVR.
• Physician experience with the balloon-expandable platform of the DurAVR® THV.
• Hemodynamic results from patients implanted with DurAVR® THV.
• Flow dynamics and the importance of laminar flow.